Ezra – an AI-based healthcare company transforming MRI imaging and early cancer detection – announced that it has raised $21 million in new funding. The round was co-led by Healthier Capital and led by Amir Dan Rubin, former CEO of Amazon’s One Medical. And FirstMark Capital co-led the round, with participation from Allianz Life Ventures (the venture capital arm of Allianz Life Insurance Company of North America), the Schwarzman family, former Chairman of England’s National Health Service (NHS) Lord David Prior, Gaingels, Republic, and Mana Ventures. The existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, Vlad Tenev, Anne Wojcicki, and Esther Dyson also participated. And Amir Dan Rubin will also join Ezra’s Board of Directors.
This funding round brings Ezra’s total funding to $41 million. It will be used to accelerate the company’s expansion to 20 cities and 50 locations across North America in 2024 and advance the use of its AI technology by leading imaging centers and clinicians. Ezra utilizes FDA-cleared AI technology to reduce the time it takes to complete an MRI scan. By deploying its AI at leading imaging centers, Ezra provides consumers the ability to access full-body MRI scanning at much more affordable pricing, and supports imaging centers in increasing throughput, efficiency, and affordability.
This new funding round comes on the heels of an impactful year for Ezra. And the company doubled its revenue in 2023, and received FDA clearance for Ezra Flash AI, enabling the launch of the world’s first 30-minute full body MRI scan enhanced by AI. Ezra stands apart by utilizing its proprietary AIs across all three key components of the cancer screening process: imaging, analysis, and reporting. The three AI innovations have enabled Ezra to reduce the price of an Ezra Full Body MRI scan by 40%, making the Ezra Full Body Flash one of the most affordable full body MRI scans on the market.
Ezra will be using the new funding round to expand across all major metro areas in the US and continue building AIs to make full-body MRI scans more affordable. And the company is on track to introduce the world’s first 15-minute full-body MRI, priced at around $500, within two to three years. Ezra currently operates at 18 locations across New York, New Jersey, Los Angeles, Irvine, San Francisco, Miami, and Las Vegas.
KEY QUOTES:
“Five years ago, Ezra pioneered the full body MRI space by being the first company in the US to offer fast, accurate, affordable, AI-powered full body MRI scans. We have since scanned thousands of people and have helped countless individuals identify cancer and over 500 other types of diseases early. This year, 10 million people will receive late-stage cancer diagnoses, with survival chances below 20%. At Ezra, we aim to detect cancer early for these 10 million people, improving their chance of getting cured. I’m thrilled to join forces with Healthier Capital and Amir Dan Rubin to further our goal of making cancer screening more affordable and accessible.”
– Emi Gal, Founder and CEO of Ezra
“At Healthier Capital we are excited to see how the Ezra team, led by Founder & CEO Emi Gal, is leveraging AI in imaging to significantly increase affordability, access and outcomes.”
– Amir Dan Rubin, CEO and Founding Managing Partner at Healthier Capital
“As a long-standing board member and investor in Ezra, I have witnessed first-hand the remarkable progress and impact this company has made in the field of early cancer detection. Ezra’s recent advancements in AI-powered full body MRI scans represent a significant leap in making cancer screening more accessible and affordable, and I am incredibly proud to be part of this mission to detect cancer early for everyone.”
– Rick Heitzmann, Co-founder & Partner at FirstMark Capital
